Free weight-loss visit planner. Bring your questions to your next appointment.

Injection

Compounded Tirzepatide injection

Learn which product your clinician is discussing, why they are considering it and how they would review your progress.

Browse guides
Illustrative Pulse+ Tirzepatide injection bottle

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.

Identify the specific product

Tirzepatide acts on two hormone receptors called GIP and GLP-1. Zepbound is one FDA-approved injectable product containing tirzepatide. Ask your clinician to write down the product name and the condition they are considering it for.

Discuss what matters for you

Bring your current medicines and any questions about previous treatment. Ask what would lead the clinician to recommend another option, which effects to watch for and who to contact between appointments.

If the proposal involves compounding

A compounded product does not have FDA approval. Ask which medical need an approved option cannot meet and which licensed pharmacy would prepare the prescription.

Explore other injectables

Illustrative Pulse+ Semaglutide injection packaging

Injection

Compounded Semaglutide injection

An ingredient may appear in several products. Start with the prescription name and the reason your clinician is considering it.

Learn more
Illustrative Pulse+ Sermorelin injection packaging

Growth hormone–releasing peptide

Compounded Sermorelin injection

A separate hormone-related topic. Understanding why sermorelin came up is the first question to bring to a clinician.

Learn more

Pulse+ visit planner

Prepare for your visit

Choose what matters to you. Take your questions to a conversation with your clinician.

What would you like to discuss?

Your selections stay in this tab until you close or reload the page.